|
Post by lazyb767 on Jun 2, 2021 10:29:05 GMT -5
Liquidia Closes Acquisition of RareGenAs part of the completed transaction, former RareGen board members Paul B. Manning, of PBM Capital Group, a successful entrepreneur, accomplished investor and beneficial owner of a majority of RareGen’s equity, and Roger A. Jeffs, Ph.D., former President and Co-CEO of United Therapeutics, have been appointed to the Liquidia Corporation Board of Directors. Of the 5,550,000 shares of Liquidia Corporation common stock acquired by RareGen owners in the merger, approximately ninety-six percent of the shares are beneficially held by Messrs. Manning and Jeffs, which are subject to a six-month lock-up per the merger agreement.
|
|
|
Post by peppy on Jun 2, 2021 10:31:16 GMT -5
MNKD volume at 2 hours of trade. real time, 1,980,664 summary, 3,389,400 $3.77. -0.27. (-6.6832%) As of 11:30AM EDT. Market open.
|
|
|
Post by peppy on Jun 2, 2021 11:45:59 GMT -5
MNKD volume at 2 hours of trade. real time, 1,980,664 summary, 3,389,400 $3.77. -0.27. (-6.6832%) As of 11:30AM EDT. Market open. MNKD volume at the half day of trade, real time, 2,399,296 summary, 4,112,226 $3.75. -0.29 (-7.1782%) As of 12:45PM EDT. Market open.
|
|
|
Post by hellodolly on Jun 2, 2021 12:37:13 GMT -5
Since bad news for UTHR leads to a larger percentage drop in MNKD than in UTHR, it is pretty clear that everyone has given up on Afrezza ever being a money making drug. (Even though most agree that Afrezza is a great insulin option for some people.) Uvula, I have not given up as you alluded to in your prior post in the scripts thread, rather quite the contrary. You misinterpreted what I posted as I was saying that MNKD was not as dependent on Afrezza as it once was. My emphasis was on the value of Afrezza validating technosphere as a progressive way of treating future diseases. I never said that Afrezza would never be profitable, that was YOUR "twist" on my post. Regarding the difference in percentage loss between UTHR and MNKD sp, UTHR has a vastly different valuation and price multiple vs. earnings than MNKD so it's like comparing apples and oranges IMO. I respectfully disagree with the generalization that "everyone" has given up on Afrezza ever being a money making drug. 😉 joeypotsandpans You're too kind and wiser. I had to edit what I wanted to write several times before I finally deleted my third attempt at explaining the UTHR and MNKD comment then, said to myself, "not wasting my time today. The people here are not as dumb as some think they are and can see right through it."
|
|
|
Post by boca1girl on Jun 2, 2021 13:12:00 GMT -5
MNKD volume at 2 hours of trade. real time, 1,980,664 summary, 3,389,400 $3.77. -0.27. (-6.6832%) As of 11:30AM EDT. Market open. MNKD volume at the half day of trade, real time, 2,399,296 summary, 4,112,226 $3.75. -0.29 (-7.1782%) As of 12:45PM EDT. Market open. Peppy, where is the next level of support? Where do your charts tell you we are headed to?
|
|
|
Post by peppy on Jun 2, 2021 13:16:11 GMT -5
MNKD volume at the half day of trade, real time, 2,399,296 summary, 4,112,226 $3.75. -0.29 (-7.1782%) As of 12:45PM EDT. Market open. Peppy, where is the next level of support? Where do your charts tell you we are headed to? $3.30 is the 200 day. $3.14 and $3.12 this last delusion low.
|
|
|
Post by mytakeonit on Jun 2, 2021 14:08:08 GMT -5
$3.67 ... hey that's me putting in shares into my daughter's IRA So now ... LET'S GO !!! But, that's my version of letitride
|
|
|
Post by wyattdog on Jun 2, 2021 15:02:51 GMT -5
last trade at 16:00 was a single block trade of 1,468,597 shares at 3.71
|
|
|
Post by guidepost on Jun 2, 2021 15:44:49 GMT -5
Added 1/3rd today at 3.75, will add more at 3.5 & 3.25 if it gets there
|
|
|
Post by peppy on Jun 2, 2021 17:34:54 GMT -5
MNKD volume at 2 hours of trade. real time, 1,980,664 summary, 3,389,400 $3.77. -0.27. (-6.6832%) As of 11:30AM EDT. Market open. MNKD volume at the half day of trade, real time, 2,399,296 summary, 4,112,226 $3.75. -0.29 (-7.1782%) As of 12:45PM EDT. Market open. MNKD Nasdaq real time volume, 7,560,931 shares. MNKD Nasdaq summary volume, 9,153,712 shares. Avg. Volume 4,621,514 $3.71. -0.33 (-8.17%) At close: 4:00PM EDT
|
|
|
Post by babaoriley on Jun 2, 2021 17:52:45 GMT -5
My buyout is coming! At $2.75 unfortunately.
|
|
|
Post by longliner on Jun 2, 2021 18:55:09 GMT -5
My buyout is coming! At $2.75 unfortunately. I suggest you quickly sell if you believe this. I would if I believed that.
|
|
|
Post by prcgorman2 on Jun 3, 2021 7:42:55 GMT -5
last trade at 16:00 was a single block trade of 1,468,597 shares at 3.71 If MNKD was added to an index that rebalances at these levels of volume at the end of every trading day, that will be an interesting new thing although I would prefer the volume tended to be heavier on the buy side than on the sell. Other than when Sanofi signed a $1B+ worldwide marketing agreement for Afrezza, things have never looked better for Mannkind. The Liquidia news is old so I doubt that is driving volume much, but perhaps I misunderstand the potential impact of a competitive PAH medication. I’ve assumed the market baked in revenue projections based on a competitive market.
|
|
|
Post by peppy on Jun 3, 2021 9:05:11 GMT -5
off the top of my head..... it looks like MNKD wants $4.00 again. we will see, decent volume. support and resistance and all.
|
|
|
Post by peppy on Jun 3, 2021 9:30:49 GMT -5
|
|